HPV Management in Developing Countries

The management of human papillomavirus (HPV) in developing countries is a complex and pressing public health challenge. HPV, a common sexually transmitted infection, is associated with a range of diseases, including cervical cancer, which disproportionately affects women in low-resource settings. This chapter provides a concise overview of the prevalence, morbidity, mortality, and multifaceted burden of HPV in developing countries, highlighting the critical need for comprehensive management strategies. Prevalence studies reveal a high incidence of HPV in developing regions, where limited access to healthcare services and cultural factors can hinder prevention and early detection efforts. Consequently, HPV-related morbidity and mortality rates are alarmingly high, particularly due to cervical cancer. The burden of HPV extends beyond the clinical sphere, encompassing economic, social, and psychological dimensions that affect individuals and communities. Addressing HPV in developing countries necessitates a multi-pronged approach encompassing vaccination, education, screening, treatment, and support services. Universal HPV vaccination programs, accessible healthcare, culturally sensitive education campaigns, and the integration of telemedicine and online resources are among the key recommendations. Collaboration with international organizations, NGOs, and advocacy groups is instrumental in securing resources and expertise for HPV management. While progress has been made, challenges persist, including financial barriers, gender disparities, and the need to reach marginalized populations. This chapter underscores the urgency of continued efforts to mitigate the burden of HPV in developing countries. By implementing comprehensive strategies and addressing the unique needs of their populations, these nations can reduce the prevalence of HPV infections, prevent associated diseases, and improve the overall health and well-being of their citizens.